78/100B107.460
USD
1.63
(1.54%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Edwards Lifesciences net income 1999–2026What is an income statement? The income statement shows a company's revenue, costs and profit over a quarter or a year, from sales at the top to net income at the bottom.
Edwards Lifesciences earned 307.50M USD in Q3 FY2026, the three months to 30 September 2026, up 5.6% on the same quarter a year before. Edwards Lifesciences's net income over the last twelve months was 1.02B USD, down 25.3% on the twelve months before. In fiscal year 2025 it earned 1.07B USD, down 74.3% on the year before.
Last updated 10 Nov 2026 · Next report 9 Feb 2027
Net income
Net income · +8.1% a year over 10 yearsNet margin
Growth
| Fiscal year | Period ending | Net income | Growth | Net margin | Revenue |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 1.02B | -25.34% | 15.30% | 6.67B |
| FY2025 | 31 Dec 2025 | 1.07B | -74.28% | 17.69% | 6.07B |
| FY2024 | 31 Dec 2024 | 4.17B | +197.68% | 76.75% | 5.44B |
| FY2023 | 31 Dec 2023 | 1.40B | -7.85% | 27.99% | 5.01B |
| FY2022 | 31 Dec 2022 | 1.52B | +1.25% | 28.28% | 5.38B |
| FY2021 | 31 Dec 2021 | 1.50B | +82.55% | 28.73% | 5.23B |
| FY2020 | 31 Dec 2020 | 823.40M | -21.35% | 18.77% | 4.39B |
| FY2019 | 31 Dec 2019 | 1.05B | +44.96% | 24.08% | 4.35B |
| FY2018 | 31 Dec 2018 | 722.20M | +16.09% | 19.40% | 3.72B |
| FY2017 | 31 Dec 2017 | 622.10M | +9.24% | 18.11% | 3.44B |
| FY2016 | 31 Dec 2016 | 569.50M | +15.07% | 19.22% | 2.96B |
| FY2015 | 31 Dec 2015 | 494.90M | -38.98% | 19.85% | 2.49B |
| FY2014 | 31 Dec 2014 | 811.10M | +107.07% | 34.92% | 2.32B |
| FY2013 | 31 Dec 2013 | 391.70M | +33.59% | 19.15% | 2.05B |
| FY2012 | 31 Dec 2012 | 293.20M | +23.87% | 15.43% | 1.90B |
| FY2011 | 31 Dec 2011 | 236.70M | +8.58% | 14.10% | 1.68B |
| FY2010 | 31 Dec 2010 | 218.00M | -4.85% | 15.07% | 1.45B |
| FY2009 | 31 Dec 2009 | 229.10M | +77.73% | 17.34% | 1.32B |
| FY2008 | 31 Dec 2008 | 128.90M | +14.07% | 10.41% | 1.24B |
| FY2007 | 31 Dec 2007 | 113.00M | -13.41% | 10.36% | 1.09B |
| FY2006 | 31 Dec 2006 | 130.50M | +64.56% | 12.58% | 1.04B |
| FY2005 | 31 Dec 2005 | 79.30M | +4,564.71% | 7.95% | 997.90M |
| FY2004 | 31 Dec 2004 | 1.70M | -97.85% | 0.18% | 931.50M |
| FY2003 | 31 Dec 2003 | 79.00M | +41.83% | 9.18% | 860.50M |
| FY2002 | 31 Dec 2002 | 55.70M | — | 7.91% | 704.00M |
| FY2001 | 31 Dec 2001 | -12.00M | — | -1.73% | 692.00M |
| FY2000 | 31 Dec 2000 | -272.00M | -431.71% | -33.83% | 804.00M |
| FY1999 | 31 Dec 1999 | 82.00M | — | 9.06% | 905.00M |
| Quarter | Period ending | Net income | Growth on a year before | Net margin | Revenue |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 307.50M | +5.63% | 17.92% | 1.72B |
| Q2 FY2026 | 30 Jun 2026 | 241.90M | -27.40% | 13.89% | 1.74B |
| Q1 FY2026 | 31 Mar 2026 | 380.70M | +6.34% | 23.09% | 1.65B |
| Q4 FY2025 | 31 Dec 2025 | 91.20M | -76.35% | 5.81% | 1.57B |
| Q3 FY2025 | 30 Sept 2025 | 291.10M | -90.52% | 18.74% | 1.55B |
| Q2 FY2025 | 30 Jun 2025 | 333.20M | -8.39% | 21.75% | 1.53B |
| Q1 FY2025 | 31 Mar 2025 | 358.00M | +1.73% | 25.34% | 1.41B |
| Q4 FY2024 | 31 Dec 2024 | 385.60M | +4.24% | 27.83% | 1.39B |
| Q3 FY2024 | 30 Sept 2024 | 3.07B | +697.82% | 226.73% | 1.35B |
| Q2 FY2024 | 30 Jun 2024 | 363.70M | +18.43% | 26.24% | 1.39B |
| Q1 FY2024 | 31 Mar 2024 | 351.90M | +3.35% | 26.46% | 1.33B |
| Q4 FY2023 | 31 Dec 2023 | 369.90M | -7.15% | 29.21% | 1.27B |
| Q3 FY2023 | 30 Sept 2023 | 384.90M | +12.05% | 30.96% | 1.24B |
| Q2 FY2023 | 30 Jun 2023 | 307.10M | -24.43% | 24.01% | 1.28B |
| Q1 FY2023 | 31 Mar 2023 | 340.50M | -8.86% | 23.33% | 1.46B |
| Q4 FY2022 | 31 Dec 2022 | 398.40M | +18.82% | 29.55% | 1.35B |
| Q3 FY2022 | 30 Sept 2022 | 343.50M | +1.00% | 26.04% | 1.32B |
| Q2 FY2022 | 30 Jun 2022 | 406.40M | -16.98% | 29.58% | 1.37B |
| Q1 FY2022 | 31 Mar 2022 | 373.60M | +10.47% | 27.86% | 1.34B |
| Q4 FY2021 | 31 Dec 2021 | 335.30M | +8.34% | 25.22% | 1.33B |
| Q3 FY2021 | 30 Sept 2021 | 340.10M | +4.58% | 25.96% | 1.31B |
| Q2 FY2021 | 30 Jun 2021 | 489.50M | — | 35.57% | 1.38B |
| Q1 FY2021 | 31 Mar 2021 | 338.20M | +8.89% | 27.80% | 1.22B |
| Q4 FY2020 | 31 Dec 2020 | 309.50M | +10.46% | 25.97% | 1.19B |
| Q3 FY2020 | 30 Sept 2020 | 325.20M | +18.38% | 28.50% | 1.14B |
| Q2 FY2020 | 30 Jun 2020 | -121.90M | -150.31% | -13.18% | 925.00M |
| Q1 FY2020 | 31 Mar 2020 | 310.60M | +24.39% | 27.52% | 1.13B |
| Q4 FY2019 | 31 Dec 2019 | 280.20M | +3,902.86% | 23.87% | 1.17B |
| Q3 FY2019 | 30 Sept 2019 | 274.70M | +21.60% | 25.11% | 1.09B |
| Q2 FY2019 | 30 Jun 2019 | 242.30M | -14.29% | 22.29% | 1.09B |
| Q1 FY2019 | 31 Mar 2019 | 249.70M | +20.86% | 25.15% | 993.00M |
| Q4 FY2018 | 31 Dec 2018 | 7.00M | -80.39% | 0.72% | 977.70M |
| Q3 FY2018 | 30 Sept 2018 | 225.90M | +32.80% | 24.92% | 906.60M |
| Q2 FY2018 | 30 Jun 2018 | 282.70M | +51.91% | 29.96% | 943.70M |
| Q1 FY2018 | 31 Mar 2018 | 206.60M | -10.25% | 23.09% | 894.80M |
| Q4 FY2017 | 31 Dec 2017 | 35.70M | -77.48% | 4.02% | 888.50M |
| Q3 FY2017 | 30 Sept 2017 | 170.10M | +20.30% | 20.71% | 821.50M |
| Q2 FY2017 | 30 Jun 2017 | 186.10M | +47.00% | 22.11% | 841.80M |
| Q1 FY2017 | 31 Mar 2017 | 230.20M | +60.98% | 26.06% | 883.50M |
| Q4 FY2016 | 31 Dec 2016 | 158.50M | +12.65% | 20.65% | 767.70M |
| Q3 FY2016 | 30 Sept 2016 | 141.40M | +19.73% | 19.12% | 739.40M |
| Q2 FY2016 | 30 Jun 2016 | 126.60M | +12.33% | 16.67% | 759.30M |
| Q1 FY2016 | 31 Mar 2016 | 143.00M | +15.88% | 20.51% | 697.30M |
| Q4 FY2015 | 31 Dec 2015 | 140.70M | +28.85% | 20.97% | 671.10M |
| Q3 FY2015 | 30 Sept 2015 | 118.10M | +24.84% | 19.19% | 615.50M |
| Q2 FY2015 | 30 Jun 2015 | 112.70M | -79.40% | 18.27% | 616.80M |
| Q1 FY2015 | 31 Mar 2015 | 123.40M | +104.64% | 20.90% | 590.30M |
| Q4 FY2014 | 31 Dec 2014 | 109.20M | +44.06% | 17.67% | 618.00M |
| Q3 FY2014 | 30 Sept 2014 | 94.60M | +23.18% | 15.57% | 607.40M |
| Q2 FY2014 | 30 Jun 2014 | 547.00M | +486.28% | 95.11% | 575.10M |
| Q1 FY2014 | 31 Mar 2014 | 60.30M | -58.10% | 11.54% | 522.40M |
| Q4 FY2013 | 31 Dec 2013 | 75.80M | -16.79% | 14.14% | 536.00M |
| Q3 FY2013 | 30 Sept 2013 | 76.80M | +10.98% | 15.50% | 495.60M |
| Q2 FY2013 | 30 Jun 2013 | 93.30M | +37.61% | 18.04% | 517.20M |
| Q1 FY2013 | 31 Mar 2013 | 143.90M | +121.04% | 28.97% | 496.70M |
| Q4 FY2012 | 31 Dec 2012 | 91.10M | +44.37% | 17.85% | 510.50M |
| Q3 FY2012 | 30 Sept 2012 | 69.20M | +34.11% | 15.45% | 447.90M |
| Q2 FY2012 | 30 Jun 2012 | 67.80M | +16.70% | 14.07% | 482.00M |
| Q1 FY2012 | 31 Mar 2012 | 65.10M | +1.88% | 14.18% | 459.20M |
| Q4 FY2011 | 31 Dec 2011 | 63.10M | -2.62% | 14.67% | 430.20M |
| Q3 FY2011 | 30 Sept 2011 | 51.60M | +7.50% | 12.50% | 412.70M |
| Q2 FY2011 | 30 Jun 2011 | 58.10M | +1.04% | 13.47% | 431.20M |
| Q1 FY2011 | 31 Mar 2011 | 63.90M | +33.96% | 15.80% | 404.50M |
| Q4 FY2010 | 31 Dec 2010 | 64.80M | +36.13% | 16.51% | 392.40M |
| Q3 FY2010 | 30 Sept 2010 | 48.00M | -34.69% | 13.76% | 348.90M |
| Q2 FY2010 | 30 Jun 2010 | 57.50M | +21.05% | 15.74% | 365.20M |
| Q1 FY2010 | 31 Mar 2010 | 47.70M | -21.16% | 14.01% | 340.50M |
| Q4 FY2009 | 31 Dec 2009 | 47.60M | +24.93% | 13.73% | 346.70M |
| Q3 FY2009 | 30 Sept 2009 | 73.50M | +123.40% | 22.57% | 325.70M |
| Q2 FY2009 | 30 Jun 2009 | 47.50M | +19.65% | 14.16% | 335.50M |
| Q1 FY2009 | 31 Mar 2009 | 60.50M | +232.42% | 19.30% | 313.50M |
| Q4 FY2008 | 31 Dec 2008 | 38.10M | +141.14% | 12.30% | 309.70M |
| Q3 FY2008 | 30 Sept 2008 | 32.90M | +13.06% | 10.84% | 303.60M |
| Q2 FY2008 | 30 Jun 2008 | 39.70M | +13.75% | 12.12% | 327.60M |
| Q1 FY2008 | 31 Mar 2008 | 18.20M | -45.18% | 6.13% | 296.80M |
| Q4 FY2007 | 31 Dec 2007 | 15.80M | -23.67% | 5.39% | 293.00M |
| Q3 FY2007 | 30 Sept 2007 | 29.10M | +4.68% | 11.13% | 261.40M |
| Q2 FY2007 | 30 Jun 2007 | 34.90M | -3.32% | 12.80% | 272.60M |
| Q1 FY2007 | 31 Mar 2007 | 33.20M | -27.83% | 12.57% | 264.10M |
| Q4 FY2006 | 31 Dec 2006 | 20.70M | -46.37% | 7.79% | 265.60M |
| Q3 FY2006 | 30 Sept 2006 | 27.80M | — | 11.24% | 247.40M |
| Q2 FY2006 | 30 Jun 2006 | 36.10M | +159.71% | 13.51% | 267.30M |
| Q1 FY2006 | 31 Mar 2006 | 46.00M | +47.44% | 17.90% | 257.00M |
| Q4 FY2005 | 31 Dec 2005 | 38.60M | +49.03% | 15.46% | 249.70M |
| Q3 FY2005 | 30 Sept 2005 | -4.40M | -135.48% | -1.83% | 240.90M |
| Q2 FY2005 | 30 Jun 2005 | 13.90M | -45.49% | 5.38% | 258.20M |
| Q1 FY2005 | 31 Mar 2005 | 31.20M | — | 12.53% | 249.10M |
| Q4 FY2004 | 31 Dec 2004 | 25.90M | +37.04% | 10.92% | 237.10M |
| Q3 FY2004 | 30 Sept 2004 | 12.40M | -49.39% | 5.52% | 224.80M |
| Q2 FY2004 | 30 Jun 2004 | 25.50M | +20.85% | 10.87% | 234.60M |
| Q1 FY2004 | 31 Mar 2004 | -62.10M | -528.28% | -26.43% | 235.00M |
| Q4 FY2003 | 31 Dec 2003 | 18.90M | -12.90% | 8.43% | 224.10M |
| Q3 FY2003 | 30 Sept 2003 | 24.50M | — | 11.89% | 206.10M |
| Q2 FY2003 | 30 Jun 2003 | 21.10M | -31.05% | 9.69% | 217.80M |
| Q1 FY2003 | 31 Mar 2003 | 14.50M | -30.29% | 6.82% | 212.50M |
| Q4 FY2002 | 31 Dec 2002 | 21.70M | +31.52% | 10.68% | 203.10M |
| Q3 FY2002 | 30 Sept 2002 | -17.40M | -220.00% | -10.49% | 165.80M |
| Q2 FY2002 | 30 Jun 2002 | 30.60M | — | 17.71% | 172.80M |
| Q1 FY2002 | 31 Mar 2002 | 20.80M | +63.78% | 12.82% | 162.30M |
| Q4 FY2001 | 31 Dec 2001 | 16.50M | -33.47% | 10.32% | 159.90M |
| Q3 FY2001 | 30 Sept 2001 | 14.50M | +229.55% | 9.81% | 147.80M |
| Q2 FY2001 | 30 Jun 2001 | -55.70M | — | -28.95% | 192.40M |
| Q1 FY2001 | 31 Mar 2001 | 12.70M | -25.29% | 6.62% | 191.90M |
| Q4 FY2000 | 31 Dec 2000 | 24.80M | +24.00% | 11.45% | 216.50M |
| Q3 FY2000 | 30 Sept 2000 | 4.40M | — | 2.37% | 185.80M |
| Q2 FY2000 | 30 Jun 2000 | -309.00M | — | -150.73% | 205.00M |
| Q1 FY2000 | 31 Mar 2000 | 17.00M | — | 7.52% | 226.00M |
| Q4 FY1999 | 31 Dec 1999 | 20.00M | — | 8.55% | 234.00M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Edwards Lifesciences's profit
Source: Financial Modeling Prep